Clinical trial NCT04988009: Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology
Official title: Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology
Study type: OBSERVATIONAL
Overall status: RECRUITING
Conditions: Central Nervous System Neoplasm
Leptomeningeal Neoplasm
Metastatic Malignant Neoplasm in the Brain
Primary Brain Neoplasm
Lead sponsor: M.D. Anderson Cancer Center
Sponsor class: OTHER
First posted: 2021-08-03
Enrollment: 200
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patients with encounters at the Brain and Spine Center between 4/20/2020 and either (1) 8/30/2020 or (2) date that the state of emergency secondary to the COVID-19 pandemic is declared terminated in the United States of America- whichever date is earlier

Brief summary: This study evaluates patient perceptions around quality of care through telemedicine in neuro-oncology. Studying questionnaires related to perceptions quality of care through telemedicine in patients with brain cancer may help doctors to improve the delivery of care through this modality.

Detailed description: PRIMARY OBJECTIVE:

I. To evaluate the patient-perceived quality of care by group (telemedicine versus in-person visits) in patients with central nervous system (CNS) cancer.

SECONDARY OBJECTIVES:

I. To characterize the visits provided by telemedicine compared to those in-person.

II. To contrast the average time spent on telemedicine visits compared to in-person visits, and the delay between visit order placement and visit occurring.

III. To evaluate the domains of patient care addressed on a telemedicine visit versus in-person visit per documentation, including (1) treatment planning, (2) symptom burden, (3) goals of care.

IV. To evaluate frequency of acute care sought (through emergency room or urgent care clinic) within 30 days of encounter in telemedicine visit versus (vs) in-person visit.

V. The impact of patient and clinical characteristics on perceived quality of care in the context of covariate-adjusted modeling.

OUTLINE:

Patients complete a survey related to their perceived quality of care via telephone and have their medical chart reviewed prospectively.

Eligibility criteria: Inclusion Criteria:

* Patients with a CNS tumors: this includes patients with primary brain tumors, brain metastases, and leptomeningeal disease
* Established patients with a follow up encounter with Neuro-Oncology at the Brain and Spine Center at the University of Texas MD Anderson Cancer Center; this encounter can be

  * An in-person visit
  * A telemedicine appointment

Exclusion Criteria:

* Encounter occurred with the assistance of official language translation support
* Patients with telephone encounters (without interactive video)
* New patient or consult visits
* Neither patient nor caregiver present during the visit are available or able to answer survey questions

Primary outcomes:
measure: Survey response to question 6 of the quality of care survey ("I felt I received good medical care during this encounter")
timeFrame: through study completion, an average of 1 year
Secondary outcomes:
measure: Quality of Care Survey
timeFrame: through study completion, an average of 1 year
measure: Patients and clinical characteristics
timeFrame: Baseline
measure: Interactive time spent during visit
timeFrame: through study completion, an average of 1 year
measure: Time from visit order placement to visit occurring
timeFrame: through study completion, an average of 1 year
measure: Domains of patient care addressed during a visit, including treatment planning, symptom burden, and goals of care
timeFrame: through study completion, an average of 1 year
measure: Incidence of acute care sought (through emergency room or urgent care clinic)
timeFrame: Within 30 days of encounter
Other outcomes:
Locations:
city: Houston
country: United States
facility: M D Anderson Cancer Center
state: Texas
Study officials:
affiliation: M.D. Anderson Cancer Center
name: Barbara J O'Brien, MD
role: PRINCIPAL_INVESTIGATOR
References: